Basic Information
Qrons, founded in 2016, is a publicly traded clinical biotechnology company dedicated to developing advanced cell-based solutions to combat nerve injuries. Although they focus on traumatic brain injury (TBI), their technology can treat various neurodegenerative diseases.
QRONS INC.
NewYork,NewYork,United States of America
less than 15 people
January 01, 2016
info@qrons.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios